Gulf sub-group analysis of the real-world Orion study
Prof. Mohamed Hassanein, consultant Endocrinologist, Dubai hospital, Chair of DAR international alliance, presenting safety and effectiveness of insulin glargine 300 U/ml in participants with T2DM who fast during Ramadan in Gulf region.
![KOL_Diabetes_&_Ramadan_Talk3_(1)](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-bh/campus-sanofi-bh-new/science/Images/image---2023-10-05T172011.302-(1).png/jcr:content/image%20-%202023-10-05T172011.302%20(1).png)
KOL_Diabetes_&_Ramadan_Talk3_(1)
Related articles
MAT-BH-2200398/V1/April2022